Latest Tariffs News

Pharmaceutical manufacturer ANO has been hit with a US FDA Import Alert, joining several Australian peers amid wider regulatory tensions. The company is mobilising expert consultants and preparing a petition to lift the alert within weeks.

Burgundy Diamond Mines' subsidiary Arctic Canadian Diamond Company has secured a C$115 million senior secured loan from Canada's LETL facility to support operations amid US tariffs impacting diamond markets. The funding enables continued development and operational restructuring at the Ekati mine.

Pacific Lime and Cement Limited has formalised a pivotal Project Development Agreement with the Papua New Guinea government, marking a major step forward for its Central Lime and Cement Project and signalling strong sovereign support.

Savana Asset Management marks the first anniversary of its Savana US Small Caps Active ETF (ASX, SVNP), reporting a strong 13.62% annualised return that outpaced its benchmark despite a volatile US market. The firm also reveals insights from a novel AI stress test highlighting current limitations of large language models in investment decision-making.

TZ Limited has successfully raised $750,000 through a placement, boosted by strong shareholder support, while advancing key contracts with Microsoft and planning significant debt reduction.

Alara Resources has successfully commissioned its Al Wash-hi Majaza Copper Concentrator Plant in Oman, marking a key milestone as it begins copper-gold concentrate shipments and advances exploration across multiple licences.

Gale Pacific’s FY25 results show resilience amid tariff challenges, with strategic manufacturing diversification and brand refresh underway to drive future growth.

Gale Pacific’s FY25 results reveal a challenging year marked by tariff disruptions in the Americas, prompting a strategic overhaul of its US operations to safeguard future growth.

Select Harvests Limited delivered a robust FY2025 with net profit soaring to $31.8 million and net debt slashed by over 50%, despite a smaller almond crop. Strategic investments in processing and sales underpin a confident outlook.

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.